|
1
|
Choi C, Rim B and Kim J: Development and
evaluation of a assistive computer interface by SEMG for
individuals with spinal cord injuries. IEEE Int Conf Rehabil Robot.
2011:pp. 59753862011; PubMed/NCBI
|
|
2
|
Nussbaum EL, Flett H, Hitzig SL,
McGillivray C, Leber D, Morris H and Jing F: Ultraviolet-C
irradiation in the management of pressure ulcers in people with
spinal cord injury: A randomized, placebo-controlled trial. Arch
Phys Med Rehabil. 94:650–659. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allison DJ and Ditor DS: Targeting
inflammation to influence mood following spinal cord injury: A
randomized clinical trial. J Neuroinflammation. 12:2042015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang ML, Li JJ, Gao F, Du LJ, Zhao HP,
Wang YM, Yang DG, Chen L, Liu HW, Yang HD, et al: A preliminary
evaluation of the surgery to reconstruct thoracic breathing in
patients with high cervical spinal cord injury. Spinal Cord.
52:564–569. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ancha HR, Spungen AM, Bauman WA, Rosman
AS, Shaw S, Hunt KK, Post JB, Galea M and Korsten MA: Clinical
trial: The efficacy and safety of routine bowel cleansing agents
for elective colonoscopy in persons with spinal cord injury- a
randomized prospective single-blind study. Aliment Pharmacol Ther.
30:1110–1117. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Celik EC, Erhan B, Gunduz B and Lakse E:
The effect of low-frequency TENS in the treatment of neuropathic
pain in patients with spinal cord injury. Spinal Cord. 51:334–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Apostolidis A, Thompson C, Yan X and
Mourad S: An exploratory, placebo-controlled, dose-response study
of the efficacy and safety of onabotulinumtoxinA in spinal cord
injury patients with urinary incontinence due to neurogenic
detrusor overactivity. World J Urol. 31:1469–1474. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grossman RG, Fehlings MG, Frankowski RF,
Burau KD, Chow DS, Tator C, Teng A, Toups EG, Harrop JS, Aarabi B,
et al: A prospective, multicenter, phase I matched-comparison group
trial of safety, pharmacokinetics, and preliminary efficacy of
riluzole in patients with traumatic spinal cord injury. J
Neurotrauma. 31:239–255. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang ML, Li JJ, So KF, Chen JY, Cheng WS,
Wu J, Wang ZM, Gao F and Young W: Efficacy and safety of lithium
carbonate treatment of chronic spinal cord injuries: A
double-blind, randomized, placebo-controlled clinical trial. Spinal
Cord. 50:141–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Van Straaten MG, Cloud BA, Morrow MM,
Ludewig PM and Zhao KD: Effectiveness of home exercise on pain,
function, and strength of manual wheelchair users with spinal cord
injury: A high-dose shoulder program with telerehabilitation. Arch
Phys Med Rehabil. 95:1810–1817 e2. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lobenwein D, Tepeköylü C, Kozaryn R,
Pechriggl EJ, Bitsche M, Graber M, Fritsch H, Semsroth S, Stefanova
N, Paulus P, et al: shock wave treatment protects from neuronal
degeneration via a toll-like receptor 3 dependent mechanism:
Implications of a first-ever causal treatment for ischemic spinal
cord injury. J Am Heart Assoc. 4:e0024402015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Freria CM, Bernardes D, Almeida GL, Simões
GF, Barbosa GO and Oliveira AL: Impairment of toll-like receptors 2
and 4 leads to compensatory mechanisms after sciatic nerve axotomy.
J Neuroinflammation. 13:1182016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li XQ, Lv HW, Tan WF, Fang B, Wang H and
Ma H: Role of the TLR4 pathway in blood-spinal cord barrier
dysfunction during the bimodal stage after ischemia/reperfusion
injury in rats. J Neuroinflammation. 11:622014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang Q, Yu F, Cui X, Duan J, Wu Q,
Nagarkatti P and Fan D: Sparstolonin B suppresses
lipopolysaccharide-induced inflammation in human umbilical vein
endothelial cells. Arch Pharm Res. 36:890–896. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang Q, Dong S, Lei L, Liu J, Zhang J, Li
J, Duan J and Fan D: Protective effects of Sparstolonin B, a
selective TLR2 and TLR4 antagonist, on mouse endotoxin shock.
Cytokine. 75:302–309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deng X, Zhang Y, Jiang F, Chen R, Peng P,
Wen B and Liang J: The Chinese herb-derived Sparstolonin B
suppresses HIV-1 transcription. Virol J. 12:1082015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zou NS, Liang QL, Li P, Liu J, Liu X, Kang
A and Deng HS: Determination of sparstolonin B by ultra-high
performance liquid chromatography coupled with triple quadrupole
mass spectrometry: Application to pharmacokinetic study of
sparstolonin B in rat plasma. Biomed Chromatogr. 29:1486–1491.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Q, Li J, Liang Q, Wang D, Luo Y, Yu F,
Janicki JS and Fan D: Sparstolonin B suppresses rat vascular smooth
muscle cell proliferation, migration, inflammatory response and
lipid accumulation. Vascul Pharmacol 67–69. 1–66. 2015.
|
|
19
|
Darouiche RO, Al Mohajer M, Siddiq DM and
Minard CG: Short versus long course of antibiotics for
catheter-associated urinary tract infections in patients with
spinal cord injury: A randomized controlled noninferiority trial.
Arch Phys Med Rehabil. 95:290–296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wadsworth BM, Haines TP, Cornwell PL,
Rodwell LT and Paratz JD: Abdominal binder improves lung volumes
and voice in people with tetraplegic spinal cord injury. Arch Phys
Med Rehabil. 93:2189–2197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim DI, Lee H, Lee BS, Kim J and Jeon JY:
Effects of a 6-week indoor hand-bike exercise program on health and
fitness levels in people with spinal cord injury: A randomized
controlled trial study. Arch Phys Med Rehabil. 96:2033–2040 e1.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim Y, Jo SH, Kim WH and Kweon OK:
Antioxidant and anti-inflammatory effects of intravenously injected
adipose derived mesenchymal stem cells in dogs with acute spinal
cord injury. Stem Cell Res Ther. 6:2292015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ak H, Gülşen İ, Karaaslan T, Alaca İ,
Candan A, Koçak H, Atalay T, Çelikbilek A, Demir İ and Yılmaz T:
The effects of caffeic acid phenethyl ester on inflammatory
cytokines after acute spinal cord injury. Ulus Travma Acil Cerrahi
Derg. 21:96–101. 2015.PubMed/NCBI
|
|
24
|
Hsieh SM, Wang YH, Chang SC and Huang TS:
Low dose HIV-1 Tat improves the defective nuclear factor
(NF)-kappaB activity of dendritic cells from persons with spinal
cord injury. Cell Immunol. 257:105–110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chu LW, Chen JY, Wu PC and Wu BN:
Atorvastatin prevents neuroinflammation in chronic constriction
injury rats through nuclear NFκB downregulation in the dorsal root
ganglion and spinal cord. ACS Chem Neurosci. 6:889–898. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chengke L, Weiwei L, Xiyang W, Ping W,
Xiaoyang P, Zhengquan X, Hao Z, Penghui Z and Wei P: Effect of
infliximab combined with methylprednisolone on expressions of
NF-κB, TRADD, and FADD in rat acute spinal cord injury. Spine
(Phila Pa 1976). 38:E861–E869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang N, Hai Y, Yang J, Liang F and Gao CJ:
Hyperbaric oxygen intervention reduces secondary spinal cord injury
in rats via regulation of HMGB1/TLR4/NF-κB signaling pathway. Int J
Clin Exp Pathol. 8:1141–1153. 2015.PubMed/NCBI
|
|
28
|
Kuang X, Huang Y, Gu HF, Zu XY, Zou WY,
Song ZB and Guo QL: Effects of intrathecal epigallocatechin
gallate, an inhibitor of Toll-like receptor 4, on chronic
neuropathic pain in rats. Eur J Pharmacol. 676:51–56. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang YK, Liu JT, Peng ZW, Fan H, Yao AH,
Cheng P, Liu L, Ju G and Kuang F: Different TLR4 expression and
microglia/macrophage activation induced by hemorrhage in the rat
spinal cord after compressive injury. J Neuroinflammation.
10:1122013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Impellizzeri D, Ahmad A, Di Paola R,
Campolo M, Navarra M, Esposito E and Cuzzocrea S: Role of Toll like
receptor 4 signaling pathway in the secondary damage induced by
experimental spinal cord injury. Immunobiology. 220:1039–1049.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liang Q, Wu Q, Jiang J, Duan J, Wang C,
Smith MD, Lu H, Wang Q, Nagarkatti P and Fan D: Characterization of
sparstolonin B, a Chinese herb-derived compound, as a selective
Toll-like receptor antagonist with potent anti-inflammatory
properties. J Biol Chem. 286:26470–26479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu JM, Tao LJ, Fu D, Lv ZP, Li L and Dai
RP: Activation of interleukin-1 beta (IL-1 beta) signaling in the
spinal cord in the rats with experimental cardiac injury. Int J
Cardiol. 128:413–418. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang M, Xiu L, Diao J, Wei L and Sun J:
Sparstolonin B inhibits lipopolysaccharide-induced inflammation in
3T3-L1 adipocytes. Eur J Pharmacol. 769:79–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu C, Wu F, Mao C, Wang X, Zheng T, Bu L,
Mou X, Zhou Y, Yuan G, Wang S and Xiao Y: Excess iodine promotes
apoptosis of thyroid follicular epithelial cells by inducing
autophagy suppression and is associated with Hashimoto thyroiditis
disease. J Autoimmun. 75:50–57. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Raad H, Eskalli Z, Corvilain B, Miot F and
De Deken X: Thyroid hydrogen peroxide production is enhanced by the
Th2 cytokines, IL-4 and IL-13, through increased expression of the
dual oxidase 2 and its maturation factor DUOXA2. Free Radic Biol
Med. 56:216–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee J, Yi S, Kang YE, Chang JY, Kim JT,
Sul HJ, Kim JO, Kim JM, Kim J, Porcelli AM, et al: Defective
ciliogenesis in thyroid hurthle cell tumors is associated with
increased autophagy. Oncotarget. 7:79117–79130. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koc A, Batar B, Celik O, Onaran I, Tasan E
and Sultuybek GK: Polymorphism of the NFKB1 affects the serum
inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish
population. Immunobiology. 219:531–536. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu P, Liao LY, Zhao TT, Mo XM, Chen GG
and Liu ZM: GPER/ERK&AKT/NF-κB pathway is involved in
cadmium-induced proliferation, invasion and migration of
GPER-positive thyroid cancer cells. Mol Cell Endocrinol. 442:68–80.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pringle DR, Vasko VV, Yu L, Manchanda PK,
Lee AA, Zhang X, Kirschner JM, Parlow AF, Saji M, Jarjoura D, et
al: Follicular thyroid cancers demonstrate dual activation of PKA
and mTOR as modeled by thyroid-specific deletion of Prkar1a and
Pten in mice. J Clin Endocrinol Metab. 99:E804–E812. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xian H, Wang F, Teng W, Yang D and Zhang
M: Thyroid hormone induce a p53-dependent DNA damage through
PI3K/Akt activation in sperm. Gene. 615:1–7. 2017. View Article : Google Scholar : PubMed/NCBI
|
